Literature DB >> 26617351

Diagnosing Hidradenitis Suppurativa.

Jean E Revuz1, Gregor B E Jemec2.   

Abstract

Three diagnostic criteria must be met for hidradenitis suppurativa: typical lesions, occurrence in one or more of the predilection areas, and that it is chronic and/or recurrent. Several outcome measures are used, including patient-reported pain and itch scales, Dermatology Life Quality Index, and Skindex. Hidradenitis suppurativa is associated with significant comorbidities that must be addressed in the evaluation of the patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidity; Diagnostic criteria; Hidradenitis suppurativa; Patient-reported outcome measures; Quality of life; Signs

Mesh：

Year:  2016        PMID： 26617351     DOI： 10.1016/j.det.2015.08.009

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  13 in total

Review 1.  Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Authors:  Caroline Vinkel; Simon Francis Thomsen
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

3.  A unique pneumopathy in a patient with skin nodules and abscesses.

Authors:  Giovanni Damiani; Nicola di Meo; Angelo Valerio Marzano
Journal:  Intern Emerg Med       Date:  2017-04-07       Impact factor: 3.397

4.  Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa.

Authors:  Tina Boortalary; Kanchan Misra; Sean McNish; Derek Jones; Victoria K Shanmugam
Journal:  J Dermatolog Treat       Date:  2018-01-22       Impact factor: 3.359

5.  Prevalence of antinuclear antibodies in hidradenitis suppurativa.

Authors:  Shaunak Mulani; Sean McNish; Derek Jones; Victoria K Shanmugam
Journal:  Int J Rheum Dis       Date:  2018-05       Impact factor: 2.454

6.  Quality of life in patients with early- and late-onset hidradenitis suppurativa.

Authors:  F Sampogna; L Fania; S Mastroeni; R Fusari; A Panebianco; D Abeni
Journal:  Arch Dermatol Res       Date:  2022-08-23       Impact factor: 3.033

7.  Holistic health record for Hidradenitis suppurativa patients.

Authors:  Paola Maura Tricarico; Chiara Moltrasio; Anton Gradišek; Angelo V Marzano; Vincent Flacher; Wacym Boufenghour; Esther von Stebut; Matthias Schmuth; Wolfram Jaschke; Matjaž Gams; Michele Boniotto; Sergio Crovella
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

8.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

Review 9.  Hidradenitis suppurativa: an update on connecting the tracts.

Authors:  Mallory K Smith; Cynthia L Nicholson; Angela Parks-Miller; Iltefat H Hamzavi
Journal:  F1000Res       Date:  2017-07-28

Review 10.  Gender differences in sexual health impairment in hidradenitis suppurativa: A systematic review.

Authors:  Danielle Yee; Erin K Collier; Swetha Atluri; Joanna Jaros; Vivian Y Shi; Jennifer L Hsiao
Journal:  Int J Womens Dermatol       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.